We are committed to transforming the lives of people affected by cancer or rare disease, globally. We continuously strive to uncover opportunities which address gaps across adult and paediatric care.

Helping the people with few or no options available is at the heart of everything we do. 

EUSA Pharma is part of Recordati Rare Diseases (recordatirarediseases.com), the business unit dedicated to rare disease in the Recordati group. 

Recordati has a total staff of more than 4,300, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. More information can be found in the press release: https://www.recordati.com/resources/Pubblicazione/___58a6bc05f57c4861aae203c930cd1682_/eusa-closing-pr.pdf

We see a need. We work together. We don’t give up.


Health Care

Pharmaceutical

EUSA Pharma

Nathalie Magee

Eric Hurel

Ignacio Alvarez

Alvina To

Frankie S.

Janet Otts-Watson

Gaël le Rouzo

Aurélien Millet

Rick Baker

Lesley Watson

The Market Access and Sales team at EUSA Pharma plays a critical role in ensuring that innovative pharmaceutical solutions reach those affected by cancer and rare diseases. This team collaborates with global markets to secure pricing and reimbursement, manages key accounts, and drives national and regional sales strategies. Their goal is to bridge gaps in care and provide essential treatments to patients with limited therapeutic options.

Market Access and Sales

Medical and Regulatory Affairs

Finance & Accounting Team

Market Access and Sales

About

Team members

Other teams at EUSA Pharma

Medical and Regulatory Affairs

Finance & Accounting Team